Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).

Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties. Front Med (Lausanne) (2016) 0.75

Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev (2017) 0.75

Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70

Calcium-channel blockade and incidence of cancer in aged populations. Lancet (1996) 8.04

Do calcium channel blockers increase the risk of cancer? Am J Hypertens (1996) 4.75

Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med (2013) 4.36

Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30

Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings. BMJ (2009) 2.88

Calcium-channel blockers and risk of cancer. Lancet (1997) 2.53

Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20

Calcium channel blockers and the risk of cancer. JAMA (1998) 1.78

Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol (2014) 1.73

An algorithm to derive a numerical daily dose from unstructured text dosage instructions. Pharmacoepidemiol Drug Saf (2006) 1.71

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf (2000) 1.70

Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer (2003) 1.70

Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control (2004) 1.63

A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat (2006) 1.57

Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer (1997) 1.50

Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med (2000) 1.44

Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP) J Hum Hypertens (2000) 1.44

Treatment with calcium antagonists does not increase the risk of fatal or non-fatal cancer in an elderly mid-European population: results from STEPHY II. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly. J Hypertens (1998) 1.41

Cancer risk and mortality in users of calcium channel blockers. A cohort study. Cancer (2000) 1.36

NICE hypertension guideline 2011: evidence based evolution. BMJ (2012) 1.28

Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control (2010) 1.16

Guidelines for good database selection and use in pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2011) 1.15

Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer (1998) 1.13

Calcium channel blockers and cancer: is an association biologically plausible? Am J Hypertens (1996) 1.05

Cardiovascular medication use and risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.99

Medication use and the risk of breast cancer. Eur J Epidemiol (2007) 0.98

Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf (2004) 0.92

A comparison of electronic health records at two major Peking University Hospitals in China to United States meaningful use objectives. BMC Med Inform Decis Mak (2013) 0.87

Calcium channel blockers and cancer. Am J Med (2000) 0.83

The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database. BMC Fam Pract (2013) 0.82

Breast cancer risk and use of calcium channel blockers using Swedish population registries. JAMA Intern Med (2014) 0.82

Calcium-channel blockers and risk of cancer. Lancet (1997) 0.80

Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies. Drugs Aging (1998) 0.78

Calcium channel blocker use and the risk of prostate cancer. Am J Hypertens (1998) 0.78

Antiepileptic drugs and risk of suicide attempts: a case-control study exploring the impact of underlying medical conditions. Pharmacoepidemiol Drug Saf (2017) 0.75